EDMONTON

Metropolitan Region

Young•Educated•Growing
Read our Emerging Stories

EDMONTON

Metropolitan Region

Young•Educated•Growing
Read our Emerging Stories
EDMONTON

Metropolitan Region

Young•Educated•Growing
Read our Emerging Stories

EDMONTON

Metropolitan Region

Young•Educated•Growing
Read our Emerging Stories

Our Reach

Our Future

What does it mean to be intelligent, to predict and influence the world, to learn, perceive, act, and think?”
— Richard Sutton, Co-founder Deepmind, Edmonton
We have an advantage working in the region because we are trained by the fast-paced energy sector. On the tech side, we benefit from a lot of local, government-based support and are able to hire some great skillsets, either from universities or other diverse demographics.”
— Lori Pecorilli, Co-founder and President, LATIUM

Covid-19 Resources

We are monitoring the novel coronavirus (COVID-19) situation and are committed to offering up-to-date information. This is meant to support you in making informed decisions for your business."
— Edmonton Global

Our Team

Work With Us

MALCOLM BRUCE CEO

After spending 30 years in the military living overseas and across Canada, Malcolm chose the Edmonton Metropolitan Region as the place where his children and grandchildren could achieve their full potential without having to move elsewhere. Formerly the CEO of the Edmonton Metropolitan Region Board, Malcolm joined the newly-formed Edmonton Global in 2018. He's proud of the region's welcoming and inclusive community. It's a region where people can grow, enjoy, and thrive.

Emergent Stories

Life Sciences

U of A researcher to test whether COVID-19 antibodies provide long-term immunity

By Michael Brown

Study among 13 U of A projects receiving $11.3 million in federal funding for rapid research response to pandemic.

Alberta built an artificial intelligence powerhouse. What’s next?

Artificial Intelligence

By Scott Lilwall

Just off Highway 60, a short jaunt south of Devon, sits one of the most celebrated pieces of industrial equipment...

Entos Pharmaceuticals Announces Selection of Lead DNA Vaccine Candidates for COVID-19 and a $4.2M Award to Move Forward with Phase I/II Human Trials

Life Sciences

By John D. Lewis

Entos Pharmaceuticals (Entos), a healthcare biotechnology company developing nucleic acid medicines with its Fusogenix drug delivery platform, today announced the...